Taking OMAPURE™ : When Will I See Results?

OMAPURE™ works gradually and only some users will experience immediate improvement within the first two weeks.  Most OMAPURE™ users will begin to experience noticeable positive results in 4 to 8 weeks, but in some cases it will take up to 12 weeks. 

It takes time for EPA, the primary active ingredient in OMAPURE™, to fully work its anti-inflammatory healing powers.1-3

Several double-blind controlled clinical trials in patients with rheumatoid arthritis took up to 12-14 weeks until statistically significant results (compared to placebo) were achieved.4-6  In those clinical trials, patients experienced overall improvement, reduction in number of painful joints, increased grip strength, and reduced morning stiffness by the twelfth week. 

The benefits to you of taking OMAPURE™ become more pronounced with time.  Below are the results of a double-blind controlled clinical trial4 with the same amount of EPA as found in OMAPURE™:

A negative % change from baseline means that the patient reported a drop in severity of disease activity.

The high dose (as found in OMAPURE™) demonstrated superior effect compared to the low dose (as found in most Omega-3 brands) and placebo.  Also noteworthy is that patients who stuck with the high dose Omega-3 therapy for 12 months were able to realize an additional 50% improvement above and beyond the superior results they already obtained by the third month.

Order OMAPURE™ today!  

“The symptomatic benefit of fish oil in RA can be delayed 2-3 months.  It is important that potential users understand that this delay exists.”
Arthritis Research and Therapy, 2006


  1. Gibney MJ, Hunter B: The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system of healthy volunteers.  Eur J Clin Nutr 1993 Apr;47(4):255-9.  Abstract
  2. Sperling RI, Weinblatt M, Robin JL, Ravalese J 3rd, Hoover RL, House F, Coblyn JS et al: Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis.  Arthritis Rheum 1987 30:988-97.   Abstract
  3. Marangoni F, Angeli MT, Colli S, Eligini S, Tremoli E, Sirtori CR, Galli C: Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout.  Biochim Biophys Acta 1993 1210:55-62.  Abstract
  4. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J.  Long-term effect of n-3 fatty acid supplementation in active rheumatoid arthritis: a 12 month double blind controlled study.  Arthritis Rheum 1994; 37:824-9.   Abstract
  5. Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew LE, Sherman M: Dietary fish oil and olive oil supplementation in patients with rheumatoid arthiritis: clinical and immunologic effects.  Arthritis Rheum 1990 33:810-820.   Abstract
  6. Kremer JM, Jubiz W, Michalek A, Rynes RI, Bartholomew LE, Biagaouette J, et al: Fish oil fatty acid supplementation in active rheumatoid arthritis.  A double-blinded, controlled, crossover study.  Ann Intern Med 1987 106:497-503.    Abstract